Skip to main content

Advertisement

SpringerLink
Log in

Erenumab: from scientific evidence to clinical practice—the first Italian real-life data

  • Focus on
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tepper SJ (2019) CGRP and headache: a brief review. Neurol Sci Mar 5. doi: https://doi.org/10.1007/s10072-019-03769-8

  2. Lattanzi S, Brigo F, Trinka E, Vernieri F, Corradetti T, Dobran M, Silvestrini M (2019) Erenumab for preventive treatment of migraine: a systematic review and meta-analysis of efficacy and safety. Drugs. https://doi.org/10.1007/s40265-019-01069-1

  3. Barbanti P, Egeo G (2015) Pharmacological trials in migraine: it’s time to reappraise where the headache is and what the pain is like. Headache 55(3):439–441

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Headache and Pain Unit, Department of Neurological, Motor and Sensorial Sciences, IRCCS San Raffaele Pisana, Via della Pisana 235, 00163, Rome, Italy

    Piero Barbanti, Cinzia Aurilia, Gabriella Egeo & Luisa Fofi

  2. San Raffaele University, Rome, Italy

    Piero Barbanti

Authors
  1. Piero Barbanti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cinzia Aurilia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gabriella Egeo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luisa Fofi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Piero Barbanti.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standards

This article does not contain any original study with human subjects performed by any of the authors.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barbanti, P., Aurilia, C., Egeo, G. et al. Erenumab: from scientific evidence to clinical practice—the first Italian real-life data. Neurol Sci 40 (Suppl 1), 177–179 (2019). https://doi.org/10.1007/s10072-019-03839-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-019-03839-x

Search

Navigation